血流导向装置与传统血管内治疗颅内动脉瘤的安全性和疗效:过去10年真实世界队列研究的Meta分析
本Meta分析纳入18项直接比较血流导向装置与传统血管内治疗颅内动脉瘤的研究,共1001例血流导向装置患者和1133例传统血管内治疗患者。血流导向装置组动脉瘤尺寸更大,术中并发症风险更高(OR 1.4),但随访造影完全闭塞率更高(OR 2.55),复发(OR 0.24)和再治疗(OR 0.31)率更低。
要点
- 血流导向装置组术中并发症风险高于传统血管内治疗组(OR 1.4,95%CI 1.01-1.96,P=.045)。
- 血流导向装置组随访造影完全闭塞率更高(OR 2.55,95%CI 1.70-3.83,P<.001)。
- 血流导向装置组复发率(OR 0.24)和再治疗率(OR 0.31)均低于传统血管内治疗组。
核心结论
- 与传统血管内治疗相比,放置血流导向装置可能导致更多操作相关并发症,但安全性无差异,且长期疗效更优。
研究设计与样本
- Meta分析,纳入18项直接比较血流导向装置与传统血管内治疗造影和临床结局的研究,共1001例血流导向装置患者和1133例传统血管内治疗患者,分别实施1015例和1201例动脉瘤手术;检索PubMed、EMBASE和Cochrane数据库。
诊断标准与关键数值
- 血流导向装置组动脉瘤尺寸更大(标准均数差0.22,95%CI 0.03-0.41,P=.026)。
- 术中并发症:血流导向装置组风险高于传统血管内治疗组(OR 1.4,95%CI 1.01-1.96,P=.045)。
- 随访造影完全闭塞:血流导向装置组高于传统血管内治疗组(OR 2.55,95%CI 1.70-3.83,P<.001)。
- 复发:血流导向装置组低于传统血管内治疗组(OR 0.24,95%CI 0.12-0.46,P<.001)。
- 再治疗:血流导向装置组低于传统血管内治疗组(OR 0.31,95%CI 0.21-0.47,P<.001)。
临床应用与阅片要点
- 对比血流导向装置与传统血管内治疗时,需注意血流导向装置组动脉瘤尺寸更大,可能影响结局比较。
- 随访造影评估应关注完全闭塞、复发和再治疗情况,血流导向装置组长期完全闭塞率更高、复发和再治疗率更低。
- 术中并发症风险血流导向装置组更高,阅片和报告中需结合操作相关并发症信息。
局限性
- 部分研究为回顾性、观察性设计。
- 存在高异质性。
- 存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Although the flow diverter has advantages in the treatment of intracranial aneurysms, pooled studies that directly compare it with conventional endovascular treatments are rare.
PURPOSE: Our aim was to compare the safety and efficacy of flow-diverter and conventional endovascular treatments in intracranial aneurysms.
DATA SOURCES: We performed a comprehensive search of the literature using PubMed, EMBASE, and the Cochrane Database.
STUDY SELECTION: We included only studies that directly compared the angiographic and clinical outcomes of flow-diverter and conventional endovascular treatments.
DATA ANALYSIS: Random effects or fixed effects meta-analysis was used to pool the cumulative rate of short- and long-term angiographic and clinical outcomes.
DATA SYNTHESIS: Eighteen studies with 1001 patients with flow diverters and 1133 patients with conventional endovascular treatments were included; 1015 and 1201 aneurysm procedures were performed, respectively. The flow-diverter group had aneurysms of a larger size (standard mean difference, 0.22; 95% CI, 0.03-0.41; P = .026). There was a higher risk of complications in the flow-diverter group compared with the conventional endovascular group (OR, 1.4; 95% CI, 1.01-1.96; P = .045) during procedures. The follow-up angiographic results of flow-diverter treatment indicated a higher rate of complete occlusion (OR, 2.55; 95% CI, 1.70-3.83; P < .001) and lower rates of recurrence (OR, 0.24; 95% CI, 0.12-0.46; P < .001) and retreatment (OR, 0.31; 95% CI, 0.21-0.47; P < .001).
LIMITATIONS: Limitations include a retrospective, observational design in some studies, high heterogeneity, and selection bias.
CONCLUSIONS: Compared with the conventional endovascular treatments, the placement of a flow diverter may lead to more procedure-related complications, but there is no difference in safety, and it is more effective in the long term.
引用
- Li, Zeng, Tao, et al. The Safety and Efficacy of Flow Diversion versus Conventional Endovascular Treatment for Intracranial Aneurysms: A Meta-analysis of Real-world Cohort Studies from the Past 10 Years. AJNR Am J Neuroradiol. 2022. PMID: 35710123. doi:10.3174/ajnr.A7539
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。